Cochrane · systematic review · CD010010

Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease

Teo, E, Lockhart, K, Purchuri, SN, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library

Acute Respiratory Infections2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 42.9%Low 3 · 42.9%Moderate 1 · 14.3%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Haemophilus influenzae oral vaccination for prevention of acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease (COPD)

Population: adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis
CD010010.PUB3 (current) · 7 questions
OutcomeEffectEvidenceStatus / GRADE
Acute exacerbations (number of exacerbations/person/year)
RR 0.79 [0.57, 1.1]6 studies · 557 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Mortality (deaths during trial period)
OR 1.62 [0.63, 4.12]5 studies · 518 participantsVery low
Carriage of NTHi Not meta‐analysed
no estimate extractedNRVery low
Downgraded: inconsistency
Antibiotic prescriptions (number of courses/person/year) **Corticosteroids not meta‐analysed
RR 1.81 [1.35, 2.44]3 studies · 142 participantsLow
Downgraded: risk of bias
Hospital admissions (number of participants hospitalised during trial period)
no estimate extractedNRModerate
Downgraded: imprecision
Adverse events (number of adverse events/person/year)
RR 1.43 [0.7, 2.92]5 studies · 484 participantsLow
Downgraded: risk of bias, imprecision
Quality of life Not meta‐analysed
no estimate extractedNRVery low
Downgraded: inconsistency

Comparison

Population: adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis
CD010010.PUB2 · 7 questions
OutcomeEffectEvidenceStatus / GRADE
Acute exacerbations (number of exacerbations/person/year)
RR 0.97 [0.84, 1.12]6 studies · 557 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Mortality (deaths during trial period)
OR 1.62 [0.63, 4.12]5 studies · 518 participantsVery low
Carriage of NTHi Not meta‐analysed
no estimate extractedNRVery low
Downgraded: inconsistency
Antibiotic prescriptions (number of courses/person/year) **Corticosteroids not meta‐analysed
RR 1.81 [1.35, 2.44]3 studies · 142 participantsLow
Downgraded: risk of bias
Hospital admissions (number of patients hospitalised during trial period)
OR 0.96 [0.13, 7.04]2 studies · 358 participantsModerate
Downgraded: imprecision
Adverse events (number of adverse events/person/year)
RR 1.43 [0.7, 2.92]4 studies · 484 participantsLow
Downgraded: risk of bias, imprecision
Quality of life Not meta‐analysed
no estimate extractedNRVery low
Downgraded: inconsistency